Morie Gertz

227PUBLICATIONS
268CO-AUTHORS
Haematological tumoursPeripheral nervous systemModelling and simulationPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (227)

|Sep 12, 2026
Prophylactic dexamethasone at the time of absolute lymphocyte expansion does not mitigate risk or event-free survival for immune effector cell associated delayed neurotoxicity.

|Sep 04, 2026
Impact of Baseline Polyneuropathy Severity on Eplontersen Efficacy in the NEURO-TTRansform Clinical Trial.

|Aug 29, 2026
Subtype specific artificial intelligence modelling of cardiac amyloidosis using echocardiography and electrocardiography.

|Aug 25, 2026
Chromosome 1q Gain Defines a Plasma Cell-Dominant Adverse-Risk Subtype in AL Amyloidosis With Inferior Long-Term Survival.

|Aug 03, 2026
High prevalence of iron deficiency among daratumumab-treated newly diagnosed multiple myeloma patients.

|Jul 27, 2026
Predictors of post-transplant measurable residual disease negativity and impact on clinical outcomes in multiple myeloma.

Pageof 38

Frequent Collaborators

125 joint publications

Angela Dispenzieri

115 joint publications

Shaji S Kumar

96 joint publications

Taxiarchis V Kourelis

89 joint publications

Eli Muchtar